Clinical Trial

Reporting Negative Data in Clinical Trial Results

Reporting Negative Data in Clinical Trial Results

By

Increasingly, the scientific community is coming to realize the invaluable role that negative outcomes play in the understanding of medicine as a whole.

Phase 3 Trial for Sublingual Sufentanil for the Treatment of Moderate-to-Severe Acute Pain

Phase 3 Trial for Sublingual Sufentanil for the Treatment of Moderate-to-Severe Acute Pain

By

ARX-04 would provide a non-invasive option for moderate-to-severe acute pain in medical settings.

Sign Up for Free e-Newsletters